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As the HIV-infected population ages, the role of cellular senescence and inflammation on
co-morbid conditions and pharmacotherapy is increasingly of interest. p16INK4a expression,
a marker for aging and senescence in T-cells, is associated with lower intracellular concen-
trations of endogenous nucleotides (EN) and nucleos(t)ide reverse transcriptase inhibitors
(NRTIs). This study expands on these findings by determining whether inflammation is con-
tributing to the association of p16INK4a expression with intracellular metabolite (IM) exposure
and endogenous nucleotide concentrations.
Methods
Samples from 73 HIV-infected adults receiving daily tenofovir/emtricitabine (TFV/FTC) with
either efavirenz (EFV) or atazanavir/ritonavir (ATV/r) were tested for p16INK4a expression,
and plasma cytokine and intracellular drug concentrations. Associations between p16INK4a
expression and cytokine concentrations were assessed using maximum likelihood methods,
and elastic net regression was applied to assess whether cytokines were predictive of intra-
cellular metabolite/endogenous nucleotide exposures.
Results
Enrolled participants had a median age of 48 years (range 23–73). There were no significant
associations between p16INK4a expression and cytokines. Results of the elastic net
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regression showed weak relationships between IL-1Ra and FTC-triphosphate and deoxya-
denosine triphosphate exposures, and MIP-1β, age and TFV-diphosphate exposures.
Conclusions
In this clinical evaluation, we found no relationships between p16INK4a expression and cyto-
kines, or cytokines and intracellular nucleotide concentrations. While inflammation is known
to play a role in this population, it is not a major contributor to the p16INK4a association with
decreased IM/EN exposures in these HIV-infected participants.
Introduction
With improved antiretroviral (ARV) treatment, HIV infected patients experience increased
life spans, and aging patients are susceptible to a host of new clinical challenges [1]. These chal-
lenges include increased risk for HIV-associated non-AIDS (HANA) conditions, including
cardiovascular, renal, and hepatic disease. To date, treatment of HIV infection in older adults
remains the same as that of younger adults, with additional comorbidity screening recom-
mended as patients grow older. HIV-associated inflammation has been implicated in the early
onset of many complications typically not seen until later years of life in uninfected individuals
[2].
Tumor suppressor gene p16INK4a, is a marker of cellular senescence and biomarker for
molecular age of several tissues, including T-cells[3]. HIV is thought to induce some functions
of immunosenescence [2], which may contribute to the increased risk of age-related illness
observed in infected patients. Although the exact mechanism is not well understood, inflam-
mation may play a role. Compared to healthy individuals, patients with HIV infection have
been shown to have increased levels of inflammatory cytokines [4, 5]. Through cyclin-depen-
dent kinase pathways, p16INK4a has been shown to regulate the production of proinflammatory
cytokines such as IL-6 and IL-8 [6]. In-vitro work has shown that cells induced to senescence
exhibit senescence-associated secretory phenotype (SASP), which is characterized by increases
in GM-CSF, IL-6, -7, -8, -1β, -13, and GRO [7]. IFNγ decreases the formation of active metab-
olites of zidovudine and lamivudine in adipocytes and PBMCs [8], while TNFα has been
shown to increase zidovudine metabolite formation. Several of these same cytokines are
increased in HIV infection [9] and have been related to increased mortality in this population
[10]. Defining the relationship between p16INK4a and markers of inflammation in HIV infected
adults will help better understand HIV-associated immune senescence [11]. Tenofovir diso-
proxil fumarate (TDF) and emtricitabine (FTC) are nucleos(t)ide reverse transcriptase inhibi-
tors (NRTIs) and are recommended in first-line combination ARV therapies regardless of age.
In order to exert their antiviral effect, they must cross the cellular membrane and undergo
phosphorylation to their respective metabolites, tenofovir diphosphate (TFV-dp) and emtrici-
tabine triphosphate (FTC-tp). We previously demonstrated that higher expression of p16INK4a
is associated with lower exposures of FTC-tp, dATP, and dCTP in HIV-infected participants
[12]. Inflammation may contribute to this relationship, as it has been shown to regulate drug
transporters, such as breast cancer resistance protein (BCRP) and P-glycoprotein 1(P-gp), on
cell membranes [13] capable of effluxing NRTIs and their metabolites [14, 15]. Inflammation
may also affect intracellular enzymes responsible for the metabolism of NRTIs [16]. While
FTC is relatively non-toxic, kidney and bone toxicity with TFV are well-described adverse
effects of the drug [17], and may potentially be related to drug concentrations [5, 18]. These
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toxicities are particularly critical in the aging population, as renal function and bone mass den-
sity decline occur naturally in this population, and TDF may compound these adverse effects.
Given these observations and potential mechanisms, we hypothesized that markers of inflam-
mation may be related to p16INK4a expression and the pharmacokinetics of NRTIs. Characterizing
these relationships will help better understand the role of inflammation in HIV pathophysiology,
with the ultimate goal of designing interventions to improve patient outcomes, such as prevalence
of co-morbid conditions. The overall objective of this analysis is two-fold: 1) to determine
whether markers of inflammation are associated with p16INK4a expression, and 2) to determine if
markers of inflammation are predictive of the observed IM/EN exposure in PBMCs.
Methods
Clinical Trial Design
A detailed description of the trial design and eligibility criteria has been previously published
(5). In short, HIV-infected adults were recruited from UNC HealthCare Infectious Diseases
Clinic (Chapel Hill, NC) and the Cone Health Regional Center for Infectious Diseases (Greens-
boro, NC). All participants received daily tenofovir disoproxil fumarate/FTC 300/200 mg with
either efavirenz 600mg or atazanavir/ritonavir 300/200mg for at least 2 weeks, and provided
four timed blood samples (predose, 2, 4–6, 10–14 hours post-dose).
The study protocol was approved by the Institutional Review Boards of both institutions
(Clinicaltrials.gov NCT01180075), and conducted in accordance with all ethical standards,
and in accordance with the principles of good clinical practice and all applicable regulatory
requirements. The University of North Carolina at Chapel Hill Biomedical Institutional
Review Board approved this study as IRB 09–2120. Its most recent approval after annual
renewal (closed to enrollment, data analysis only) was July 7, 2016. Participants provided writ-
ten consent, and went through a standard informed consent process involving: review of the
IRB-approved consent form with trained study staff; time to review the consent form without
study staff present; time to ask questions; and questioning by study staff determine that the
participant understands the requirements of the study. Study staff witnessed the signing and
dating the informed consent document and cosigned and dated the form; a copy was provided
to the participant, a copy was placed in the medical record, and the original remained in the
study chart. This standard operating procedure of the UNC Center for AIDS Research Clinical
Pharmacology and Analytical Chemistry Laboratory was described in the IRB application and
approved by the UNC Biomedical IRB for this study.
Cytokines
At one of the pharmacokinetic time points, an additional blood sample was collected, centri-
fuged at 3000 RPMs for 10 minutes, and stored at -80˚C for cytokine profiling. Measurement
of 39 cytokine concentrations was performed in the Duke Regional Biocontainment Labora-
tory (RBL) Immunology Unit (Durham, NC) using MILLIPLEX1 MAP Human Cytokine/
Chemokine Premixed 39 Plex bead-based assay kit (EMD Millipore Corporation, Billerica,
Massachusetts). Due to the large number of potential predictor variables, a subset of 16 cyto-
kines that have been associated with HIV and aging was included in the analysis: TNFα, IFNγ,
IL-1Ra, IL-6, IL-12P40, IL-12P70, IL-17α, MCP-1, MIP-1α, MIP-1β, MCP-3, MDC, GRO,
sCD40L, fractalkine, and eotaxin [4, 19–21]. The lower limits of quantification for these cyto-
kines were 3.23, 3.25, 17.87, 2.63, 3.9, 3.2, 3.21, 2.82, 3.36, 17.7, 14.3, 17.1, 19.6, 19.4, 79.0, and
4.15 pg/mL, respectively. The percentage of participants with detectable cytokine concentra-
tions were: 100% TNFα, 89% IFNγ, 93% IL-1Ra, 49% IL-6, 64% IL-12P40, 92% IL-12P70, 64%
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IL-17α, 100% MCP-1, 67% MIP-1α, 93% MIP-1β, 56% MCP-3, 100% MDC, 100% GRO, 99%
sCD40L, 93% fractalkine, and 100% eotaxin.
Pharmacokinetics & p16INK4a Expression
TFV-dp, FTC-tp, dATP, and dCTP concentrations in peripheral blood mononuclear cells
(PBMCs) were measured using LC-MS/MS in the UNC Center for AIDS Research Clinical
Pharmacology and Analytical Chemistry Laboratory [12]. Drug exposure was measured as
area under the curve (AUC) using non-compartmental analysis in Phoenix WinNonlin 6.3
(Pharsight, A Certara Company, St. Louis, MO); the linear up/log down trapezoidal method
[22] was used to calculate AUC over the dosing interval. Expression of p16INK4a was deter-
mined using validated PCR-based methods [11] and final values were log2 transformed.
Statistical Analysis
The goal of this analysis was to identify cytokines related to p16INK4a expression and IM/EN
AUCs. The causal direction of potential associations between p16INK4A and cytokine concentra-
tions is largely unknown, so unadjusted bidirectional association was tested. Because a large pro-
portion of some cytokines were below the assay limit of detection, association with p16 INK4A
was measured using a maximum likelihood approach that accounts for left censoring [23].
Cytokine concentrations were evaluated as potential predictors of IM/EN nucleotide AUCs
using a linear model with elastic net selection, a penalized regression technique [24] for select-
ing variables that are most predictive amongst a large number of correlated potential predic-
tors. Tuning parameters for the elastic net algorithm were chosen via 5-fold cross-validation
with the optimal tuning parameter values chosen to minimize predicted residual sum of
squares. To account for left-censored data, cytokines were dichotomized as detectable (1) or
undetectable (0) if more than 20% of the concentrations were below the limit of detection, and
cytokines detectable in 80% or more of participants were analyzed as continuous with results
below the limit replaced with½ the lower limit of quantification (LLQ). Chronological age in
years was also included as a potential predictor variable.
Continuous cytokine concentrations were natural-log transformed and p16INK4a measure-
ments were log2 transformed. Data were analyzed in R 3.1.2 (r-project.org) and SAS version
9.4 using the GLMSELECT procedure and the NLMIXED procedure with code adapted from
Nie and colleagues [25]. These analyses were exploratory in nature, thus no adjustment was
made for multiple testing.
Results
Study Participants
The study enrolled 79 participants receiving TFV/FTC. Of those, 54 were receiving EFV and
25 were receiving ATV/r. The median (range) age was 48 years (23–73) and the median dura-
tion of HIV infection was 10 years. Though virologically suppressed during study participa-
tion, the historical median (range) CD4+ nadir was 253 (3–868) cells/mm3, with a peak viral
load of 70,300 (50->1,000,000) copies/mL. Sixty-one percent of participants were African-
American. Detailed demographics of the study population have been published [12]. One
enrolled participant did not have a sample available for cytokine profiling. Of the remaining
78, five did not provide a sample for p16INK4a measurement and six did not provide adequate
samples for accurate calculation of IM/EN exposures. These individuals were excluded from
analysis, resulting in 73 participants available for the p16INK4a cytokine analysis, and 72 for the
exposure-cytokine analysis.
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Correlation Analysis
A considerable number of cytokines were detectable (Table 1), but some remained below the
LLQ. Five of the 16 cytokines had undetectable results in >20% of participants, six cytokines
had undetectable results in 1–20% of participants, and five cytokines were 100% detectable.
Fig 1 shows box plots of these cytokines; concentrations below the LLQ are included as half of
the LLQ value for each cytokine. Table 1 shows the maximum likelihood correlation estimates
and 95% confidence intervals for the unadjusted association between p16INK4a and each cyto-
kine. Correlation coefficient magnitudes ranged from 0.02 to0.22 and all 95% confidence
intervals contained zero. The strongest associations were between p16INK4a and interleukin-1
receptor agonist (IL-1Ra), interferon-gamma (IFNγ), macrophage-derived chemokine
(MDC), and tumor necrosis factor alpha (TNFα; estimated correlation0.2). Scatterplots of
cytokine concentrations vs. p16INK4a expression are shown in Fig 2.
Elastic Net Analysis
For elastic net regression, five cytokines were dichotomized as detectable or undetectable and
the remaining 11 were natural-log transformed. Results of the analysis are presented in
Table 2. The R2 values are presented for each outcome and represent the proportion of varia-
tion explained by predictor variables in the model. The penalized parameter estimates for the
selected variables describe the direction of prediction.
Discussion
Our earlier work identified an inverse relationship between p16INK4a expression and IM/EN
exposures. In an effort to explore these relationships further, we measured plasma cytokine
concentrations in the same study participants. Correlation analysis was used to measure the
Table 1. Correlation between natural-log transformed cytokines and log2 transformed p16INK4a
expression.
Cytokine Proportion Detectable Estimated Correlation (95% CI)
TNFα 1.00 0.20 (-0.02, 0.43)
IFNγ 0.89 0.21 (-0.02, 0.43)
IL-1Ra 0.93 0.22 (-0.01, 0.44)
IL-6 0.49 0.06 (-0.20, 0.32)
IL-12P40 0.64 0.19 (-0.05, 0.43)
IL-12P70 0.92 0.02 (-0.21, 0.26)
IL-17α 0.64 0.11 (-0.14, 0.35)
MCP-1 1.00 -0.04 (-0.27, 0.19)
MIP-1α 0.67 0.16 (-0.08, 0.40)
MIP-1β 0.93 0.13 (-0.10, 0.36)
MCP-3 0.56 0.09 (-0.16, 0.34)
MDC 1.00 0.21 (-0.01, 0.44)
GRO 1.00 0.10 (-0.13, 0.33)
sCD40L 0.99 0.13 (-0.10, 0.36)
Fractalkine 0.93 0.14 (-0.09, 0.37)
Eotaxin 1.00 -0.05 (-0.28, 0.19)
Proportion detectable denotes the proportion of participants with cytokine concentrations above the LLQ.
The estimated correlation accounts for left-censored observations (below the LLQ); 95% confidence
intervals for the correlation coefficient are provided. LLQ, lower limit of quantification.
doi:10.1371/journal.pone.0168709.t001
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association between p16INK4a expression and cytokines concentrations. A considerable num-
ber of cytokines were below the limit of quantification for this analysis, which was accounted
for using a maximum likelihood method for left-censored data. Overall, correlation between
cytokines concentrations and p16INK4a expression was weak. The magnitude of correlation
coefficients ranged from 0.02 to 0.22 and each 95% CI covered the null value. IL-1Ra showed
the strongest correlation with a coefficient of 0.22, followed by IFNγ and MDC with coeffi-
cients of 0.21 and TNFα with a coefficient of 0.20, but none were considered statistically signif-
icant. A stronger correlation was expected, as senescent cells typically exhibit SASP, which is
characterized by increases in inflammatory cytokines. However, in-vitro work in human fibro-
blasts has demonstrated that SASP may be a result of DNA damage and not a direct conse-
quence of p16INK4a activation. The absence of any strong correlation in our analysis may be
explained by Coppe and colleague’s suggestion that p16INK4a positive cells may not harbor an
in-vivo SASP [26].
From a pharmacology perspective, TFV, FTC, and their metabolites are known substrates of
several drug transporters [14, 15], and the ENs are substrates of a number of nucleotide trans-
porters [27]. Inflammation may influence the activity and expression of efflux transporters on
PBMCs [13], leading to reduced drug concentrations. The activation state of the target cells can
also affect the production of intracellular NRTI metabolites [14], and thus inflammatory pro-
cesses may play a role in NRTI metabolism. However, we did not find that cytokines predicted
IM/EN exposures. Although IL-1Ra and MIP-1β were chosen by the elastic net algorithm as sig-
nificant predictors of FTC-tp, TFV-dp, and dATP exposures, they explained<14% of the vari-
ability in exposures.
Cytokines were largely detectable in this aging, HIV-infected population; however, some
remained below the LLQ, which may bias our study results. The strength of correlations and
amount of variability explained by our models was low. Cytokine concentrations and p16INK4a
Fig 1. Boxplots of measured cytokine concentrations.
doi:10.1371/journal.pone.0168709.g001
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expression in uninfected controls were not measured here for comparison of the overall state
of inflammation in these virologically suppressed participants, though cytokine concentrations
here are similar to others’ reported values for HIV-infected, suppressed patients[28], and our
median IL-6 concentration is similar to the median concentration reported by Erlandson and
colleagues in frail HIV-infected men (2.2 vs 2.3 pg/mL)[29]. For future studies, high-sensitivity
ELISA should be considered for certain analytes, as multiplex assay can be imprecise at very low
concentrations [30]. While likely unavoidable, it should also be noted that drug AUCs, and
potentially inflammation, may be affected by increased adherence to the treatment regimen dur-
ing the study period. Our results may also be due to the fact that monocytes are likely producers
of pro-inflammatory cytokines in suppressed HIV-infected subjects, while p16INK4a expression is
Fig 2. Scatterplots of p16INK4a expression versus cytokine concentrations. Observations with quantifi-able
cytokine concentrations are displayed as blue circles; concentrations below the LLQ are displayed as red + symbols.
Cytokine concentrations and p16INK4a expression were natural-log transformed and log2 transformed, respectively. A
descriptive LOESS curve is plotted handling below LLQ values as observed. Correlation estimates were less than or
equal to 0.22 for all associations (Table 1). LLQ, lower limit of quantification.
doi:10.1371/journal.pone.0168709.g002
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measured in CD4+ T-cells. However, previous work indirectly supports a role of inflammation
in p16INK4a expression in HIV-infected patients not receiving ART with uncontrolled viremia.
[3] This work showed that excess inflammation, assumed but not measured in these viremic
patients, disrupted the typical relationship between chronologic age and p16INK4a expression. In
virologically suppressed, HIV-infected subjects, the typical relationship between the two was
observed. This suggested a relationship between systemic inflammation, which we chose to mea-
sure with a broad panel of cytokines, and p16INK4a expression, as a function of subject age.
Overall, we were unable to identify a relationship between cytokine concentrations and
p16INK4a expression, intracellular NRTI concentrations, or EN pools. This finding may under-
score the complexities in cytokine signaling and suggest the need for different biomarkers as mea-
sures of inflammation to predict these outcomes. Cytokines, particularly IL-6 [31, 32], do predict
clinical outcomes; for more subtle changes in pharmacology, other biomarkers of inflammation,
such as soluble immune cell markers, cellular immune phenotypes, or kallistatin [33] may better
predict changes that could influence drug toxicity and efficacy, and should be explored further.
Supporting Information
S1 Table. Minimal Dataset used for analysis. This table contains the data used in this analysis
for each participant. Variables: ID, participant number; Age, in years; Gender; Ethnicity; Race;
TxArm, EFV/FTC/TDF for efavirenz/emtricitabine/tenofovir disoproxil fumarate or ATV/r/
FTC/TDF for atazanavir/ritonavir/emtricitabine/tenofovir disoproxil fumarate; Tobacco use;
Alcohol use; CD4, screening visit CD4+ T-cell count, in cells/mm3; BMI, body mass index, in
kg/m2; CrCL, calculated creatinine clearance, in mL/hr; Frailty Phenotype, positive or negative;
Frailty Yes, number of positive frailty phenotype components; individual cytokine concentra-
tions, in pg/mL; CD4:CD8 ratio; log2 p16
INK4a expression; individual regimen component
calculated AUC (area under the curve) values for FTC (emtricitabine, in nghr/mL), ATV
(atavanavir, in nghr/mL), EFV (efavirenz, in nghr/mL), RTV (ritonavir, in nghr/mL), TFV
(tenofovir, in nghr/mL), FTCtp (emtricitabine triphosphate, in fmolhr/million cells), TFVdp
(tenofovir diphosphate, in fmolhr/million cells), dATP (deoxyadenosine triphosphate, in
fmolhr/million cells), dCTP (deoxycytidine triphosphate, in fmolhr/million cells), EFV_u
(unbound efavirenz, in nghr/mL), ATV_u (unbound atazanavir, in nghr/mL), RTV_u
(unbound ritonavir, in nghr/mL); unbound fraction (fu) values (as percentage) for EFV, ATV,
and RTV.
(XLSX)
Table 2. Elastic net results for TFV-dp AUC, FTC-tp AUC, dATP AUC, and dCTP AUC
Outcome n r2 Predictor Variable Parameter Estimate
FTC-tp AUC 72 0.0581 Intercept 12.22
IL-1Ra -0.1285
TFV-dp AUC 72 0.139 Intercept 7.941
MIP-1β -0.4483
Age 0.03322
dATP AUC 72 0.0578 Intercept 8.499
IL-1Ra -0.07725
dCTP AUC 72 n/a No variables selected
For intracellular drug concentrations, higher concentrations of IL-1Ra were weakly predictive of lower FTC-tp exposures, and higher MIP-1β and younger
age were predictive of lower TDF-dp exposures. Higher concentrations of IL-1Ra were also weakly predictive of lower pools of dATP, but no cytokines were
predictive of endogenous dCTP pools.
doi:10.1371/journal.pone.0168709.t002
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